This special issue aims to cover most aspects of new developments in lung cancer incidence, racial variations, lung cancer research, diagnosis, treatment modalities, and prognosis.
In detail, this issue will cover:
1. The epidemiology of lung cancer with respect to smoking but also lung cancer in never smokers and the implications for treatment
2. The detection of lung cancer including possibilities for detection of early lung cancer, blood tests, radiology, and pathology
3. The genetics of lung cancer and the methods to detect driver mutations
4. The targeted treatment
5. The treatment for patients without a targetable gene, including radiotherapy (including radiosurgery/radioablation)
6. Treatment of early lung cancer including resection by cryobiopsy
7. The diagnosis and treatment of neuroendocrine carcinomas
8. The option of immunotherapy
9. Diagnosis of minimal residual disease and the role of liquid biopsy
10. Best supportive care
Authors from several disciplines will cover these topics in an interactive way.
Accepted articles in this Special Issue will be waived from Article Processing Charges. Please submit your interest earlier and also the outline of your contribution.
Evaluating the effectiveness of artificial intelligence imaging in the qualitative diagnosis of pulmonary nodules
Sarcomatoid mesothelioma presenting as a mediastinal mass: A case report
A new immunomagnetic microfluidic device for characterizing EGFR mutations in circulating tumor cells from patients withnon-small cell lung cancer
Deregulation of Casein Kinase-2 in non-small-cell lung cancer: A subunit-specific analysis